Latest / Jersey City News Today | 2 Min News | The Daily News Now!
FDA Approves First Alzheimer’s Drug in Years | Jersey News
FDA just approved Leqembi, the first drug in years to target Alzheimer’s by clearing brain amyloid plaques—offering hope for early-stage patients, but with caveats: modest benefits, serious side effects, and a staggering $56K annual cost. The approval marks a breakthrough, yet real-world access, safety monitoring, and ongoing research will determine its true impact on the fight against this devastating disease. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.